应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02348 东瑞制药
未开盘 08-19 16:08:18
1.120
+0.020
+1.82%
最高
1.120
最低
1.100
成交量
24.00万
今开
1.100
昨收
1.100
日振幅
1.82%
总市值
16.80亿
流通市值
16.80亿
总股本
15.00亿
成交额
26.62万
换手率
0.02%
流通股本
15.00亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
东瑞制药(02348.HK)将于8月23日举行董事会会议以审批中期业绩
格隆汇资讯 · 08-12
东瑞制药(02348.HK)将于8月23日举行董事会会议以审批中期业绩
东瑞制药盘中异动 早盘股价大跌6.64%
自选股智能写手 · 07-22
东瑞制药盘中异动 早盘股价大跌6.64%
东瑞制药盘中异动 早盘股价大跌5.00%
自选股智能写手 · 07-18
东瑞制药盘中异动 早盘股价大跌5.00%
主席李其玲增持东瑞制药(02348)2.8万股 每股作价1.21港元
智通财经 · 07-08
主席李其玲增持东瑞制药(02348)2.8万股 每股作价1.21港元
【主席李其玲增持东瑞制药(02348.HK)2.8万股 每股作价1.21港元】智通财经APP获悉,香港联交所最新资料显示,7月4日,主席李其玲增持东瑞制药(02348.
智通财经 · 07-08
【主席李其玲增持东瑞制药(02348.HK)2.8万股 每股作价1.21港元】智通财经APP获悉,香港联交所最新资料显示,7月4日,主席李其玲增持东瑞制药(02348.
东瑞制药:2023年度审计委员会进行了五次会议并审查了年度财务报表
金融界港股 · 04-19
东瑞制药:2023年度审计委员会进行了五次会议并审查了年度财务报表
东瑞制药(02348)将于6月12日派发末期股息每股0.065港元
智通财经 · 03-26
东瑞制药(02348)将于6月12日派发末期股息每股0.065港元
【东瑞制药(02348.HK)将于6月12日派发末期股息每股0.065港元】智通财经APP讯,东瑞制药(02348.HK)发布公告,将于2024年6月12日派发截至2023年12月31日止年度的末期股息每股0.
智通财经 · 03-26
【东瑞制药(02348.HK)将于6月12日派发末期股息每股0.065港元】智通财经APP讯,东瑞制药(02348.HK)发布公告,将于2024年6月12日派发截至2023年12月31日止年度的末期股息每股0.
港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%
智通财经 · 03-25
港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%
东瑞制药2023年收入下降9.9% 股东溢利减少8.95%
和讯网 · 03-25
东瑞制药2023年收入下降9.9% 股东溢利减少8.95%
东瑞制药盘中异动 早盘股价大跌9.16%
自选股智能写手 · 03-25
东瑞制药盘中异动 早盘股价大跌9.16%
东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%
新浪港股 · 03-25
东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%
【东瑞制药(02348.HK)将于6月12日派发末期股息每股6.5港仙】智通财经APP讯,东瑞制药(02348.HK)公布,将于2024年6月12日派发末期股息每股6.
智通财经 · 03-24
【东瑞制药(02348.HK)将于6月12日派发末期股息每股6.5港仙】智通财经APP讯,东瑞制药(02348.HK)公布,将于2024年6月12日派发末期股息每股6.
东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙
智通财经 · 03-24
东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙
东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%
格隆汇资讯 · 03-22
东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%
东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%
智通财经 · 03-22
东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%
东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案
和讯网 · 03-08
东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案
东瑞制药(02348.HK)拟3月22日举行董事会会议批准全年业绩
格隆汇资讯 · 03-08
东瑞制药(02348.HK)拟3月22日举行董事会会议批准全年业绩
东瑞制药盘中异动 大幅拉升5.08%报1.240港元
自选股智能写手 · 03-01
东瑞制药盘中异动 大幅拉升5.08%报1.240港元
东瑞制药(02348)股价上升5.085%,现价港币$1.24
阿斯达克财经 · 03-01
东瑞制药(02348)股价上升5.085%,现价港币$1.24
加载更多
公司概况
公司名称:
东瑞制药
所属市场:
SEHK
上市日期:
--
主营业务:
东瑞制药(控股)有限公司是一家投资控股公司,主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。
发行价格:
--
{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":1.12,"timestamp":1724054898031,"preClose":1.1,"halted":0,"volume":240000,"delay":0,"floatShares":1500421000,"shares":1500421000,"eps":0.23743176,"marketStatus":"未开盘","marketStatusCode":0,"change":0.02,"latestTime":"08-19 16:08:18","open":1.1,"high":1.12,"low":1.1,"amount":266160,"amplitude":0.018182,"askPrice":1.15,"askSize":76000,"bidPrice":1.1,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":0.23700799121433744,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724117400000},"adr":0,"adjPreClose":1.1,"dividendRate":0.07081,"openAndCloseTimeList":[[1724031000000,1724040000000],[1724043600000,1724054400000]],"volumeRatio":5.769230772004438,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"2458360395","title":"东瑞制药(02348.HK)将于8月23日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2458360395","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458360395?lang=zh_cn&edition=full","pubTime":"2024-08-12 18:48","pubTimestamp":1723459686,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨东瑞制药(02348.HK)发布公告,公司将于2024年8月23日举行董事会会议,藉以考虑及批准公司及其附属公司截至2024年6月30日止六个月的中期业绩及其刊发,以及考虑派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081218482495924150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081218482495924150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2453783567","title":"东瑞制药盘中异动 早盘股价大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453783567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453783567?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611805,"startTime":"0","endTime":"0","summary":"2024年07月22日早盘09时30分,东瑞制药股票出现波动,股价快速下挫6.64%。截至发稿,该股报1.111港元/股,成交量4万股,换手率0.00%,振幅1.68%。东瑞制药股票所在的药品行业中,整体涨幅为0.07%。其相关个股中,康龙化成、君圣泰医药-B、翰森制药涨幅较大,振幅较大的相关个股有东瑞制药、石药集团、绿叶制药,振幅分别为1.68%、0.66%、0.35%。东瑞制药公司简介:东瑞制药(控股)有限公司是一家投资控股公司,主要从事非专利药物的开发、制造及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722093005941f8ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722093005941f8ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":1},{"id":"2452466061","title":"东瑞制药盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452466061","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452466061?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:40","pubTimestamp":1721266849,"startTime":"0","endTime":"0","summary":"2024年07月18日早盘09时40分,东瑞制药股票出现波动,股价大幅跳水5.00%。截至发稿,该股报1.140港元/股,成交量26万股,换手率0.02%,振幅4.17%。东瑞制药股票所在的药品行业中,整体涨幅为0.03%。其相关个股中,联康生物科技集团、康哲药业、丽珠医药涨幅较大,振幅较大的相关个股有联康生物科技集团、李氏大药厂、康龙化成,振幅分别为7.14%、4.39%、3.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718094049941f8105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718094049941f8105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2449977999","title":"主席李其玲增持东瑞制药(02348)2.8万股 每股作价1.21港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449977999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449977999?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:36","pubTimestamp":1720438614,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,7月4日,主席李其玲增持东瑞制药(02348)2.8万股,每股作价1.21港元,总金额为3.388万港元。增持后最新持股数目为7.04亿股,持股比例为46.94%。本交易涉及其他关联方:熊融礼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2449277918","title":"【主席李其玲增持东瑞制药(02348.HK)2.8万股 每股作价1.21港元】智通财经APP获悉,香港联交所最新资料显示,7月4日,主席李其玲增持东瑞制药(02348.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449277918","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449277918?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:36","pubTimestamp":1720438614,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2428611333","title":"东瑞制药:2023年度审计委员会进行了五次会议并审查了年度财务报表","url":"https://stock-news.laohu8.com/highlight/detail?id=2428611333","media":"金融界港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428611333?lang=zh_cn&edition=full","pubTime":"2024-04-19 18:51","pubTimestamp":1713523868,"startTime":"0","endTime":"0","summary":"金融界4月19日消息,东瑞制药在2023年度,其审计委员会进行了五次会议,其中两次在执行董事不在场的情况下与外聘审计师开会。本公司截至2023年12月31日止年度经审核的财务报表在提呈董事会批准前已由审计委员会审查。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/19185140328253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2422663504","title":"东瑞制药(02348)将于6月12日派发末期股息每股0.065港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422663504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422663504?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:07","pubTimestamp":1711444060,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药(02348)发布公告,将于2024年6月12日派发截至2023年12月31日止年度的末期股息每股0.065港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2422663157","title":"【东瑞制药(02348.HK)将于6月12日派发末期股息每股0.065港元】智通财经APP讯,东瑞制药(02348.HK)发布公告,将于2024年6月12日派发截至2023年12月31日止年度的末期股息每股0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2422663157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422663157?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:07","pubTimestamp":1711444060,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2422539013","title":"港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422539013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422539013?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:26","pubTimestamp":1711333581,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,东瑞制药跌超10%,截止发稿跌12.88%,报1.15港元,成交额154万港元。消息面上,公司发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元,同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。公告称,中间体及原料药销售额人民币1.29亿元,比去年下降7.8%,销售额减少人民币1102.2万元;成药销售额人民币10.22亿元,比去年下降10.2%,销售额减少人民币1.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4585","YANG","02348","YINN","07226"],"gpt_icon":0},{"id":"2422536813","title":"东瑞制药2023年收入下降9.9% 股东溢利减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422536813","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422536813?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:44","pubTimestamp":1711331095,"startTime":"0","endTime":"0","summary":"快讯摘要东瑞制药2023年业绩报告显示,公司收入11.51亿元,同比下降9.9%,股东应占溢利3.26亿元,同比减少8.95%。面对激烈市场竞争,公司采取降低成本和提高效率措施。尽管如此,业绩下降反映出东瑞制药在2023年面临的挑战。投资者关注公司未来策略及应对市场竞争的能力。末期股息计划派发每股0.065港元。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250957058b5f1190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250957058b5f1190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2422587721","title":"东瑞制药盘中异动 早盘股价大跌9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422587721","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422587721?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:30","pubTimestamp":1711330204,"startTime":"0","endTime":"0","summary":"2024年03月25日早盘09时30分,东瑞制药股票出现异动,股价快速跳水9.16%。截至发稿,该股报1.200港元/股,成交量13.2万股,换手率0.01%,振幅3.79%。东瑞制药股票所在的药品行业中,整体跌幅为0.10%。其相关个股中,三爱健康集团、康龙化成、四环医药涨幅较大,振幅较大的相关个股有三爱健康集团、东瑞制药、石药集团,振幅分别为4.44%、3.79%、0.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250930047a4eb80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250930047a4eb80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2422584953","title":"东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422584953","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422584953?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:44","pubTimestamp":1711327466,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元(人民币,下同),同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0122802.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0122802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2421692326","title":"【东瑞制药(02348.HK)将于6月12日派发末期股息每股6.5港仙】智通财经APP讯,东瑞制药(02348.HK)公布,将于2024年6月12日派发末期股息每股6.","url":"https://stock-news.laohu8.com/highlight/detail?id=2421692326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421692326?lang=zh_cn&edition=full","pubTime":"2024-03-24 18:16","pubTimestamp":1711275392,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2421266913","title":"东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2421266913","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421266913?lang=zh_cn&edition=full","pubTime":"2024-03-24 18:16","pubTimestamp":1711275392,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药(02348)公布,将于2024年6月12日派发末期股息每股6.5港仙。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2421435548","title":"东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421435548","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421435548?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:03","pubTimestamp":1711119788,"startTime":"0","endTime":"0","summary":"格隆汇3月22日丨东瑞制药(02348.HK)发布公告,截至2023年12月31日止年度,公司录得收入约人民币11.5亿元,同比减少约9.9%。母公司拥有人应占溢利约人民币3.26亿元,同比下降约9.0%。董事会建议派发年度末期股息每股为港币0.065元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223031587a7f175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223031587a7f175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2421848182","title":"东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421848182","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421848182?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:01","pubTimestamp":1711119684,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药 发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元,同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。公告称,中间体及原料药销售额人民币1.29亿元,比去年下降7.8%,销售额减少人民币1102.2万元;成药销售额人民币10.22亿元,比去年下降10.2%,销售额减少人民币1.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2417305822","title":"东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2417305822","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417305822?lang=zh_cn&edition=full","pubTime":"2024-03-08 19:53","pubTimestamp":1709898800,"startTime":"0","endTime":"0","summary":"快讯正文东瑞制药即将召开董事会会议以批准去年年报及考虑派息事宜。东瑞制药宣布,董事会将于3月22日举行会议。会议议程包括批准公司及其附属公司2023年度的业绩公告。此外,董事会还将讨论是否建议派发末期股息。投资者可关注此次会议结果,以获取公司最新的财务信息。和讯自选股写手风险提示:以上内容仅作为作者或者嘉宾的观点,不代表和讯的任何立场,不构成与和讯相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082017168b182fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082017168b182fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2417087246","title":"东瑞制药(02348.HK)拟3月22日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2417087246","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417087246?lang=zh_cn&edition=full","pubTime":"2024-03-08 17:28","pubTimestamp":1709890134,"startTime":"0","endTime":"0","summary":"格隆汇3月8日丨东瑞制药(02348.HK)发布公告,公司董事会会议将于2024年3月22日(星期五)举行,藉以(其中包括)批准刊发公司及其附属公司截至2023年12月31日止年度的全年业绩公告,以及考虑建议派发末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403081729038b17a2bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403081729038b17a2bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2416524056","title":"东瑞制药盘中异动 大幅拉升5.08%报1.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416524056","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416524056?lang=zh_cn&edition=full","pubTime":"2024-03-01 13:26","pubTimestamp":1709270809,"startTime":"0","endTime":"0","summary":"2024年03月01日下午盘13时26分,东瑞制药股票出现异动,股价大幅拉升5.08%。截至发稿,该股报1.240港元/股,成交量22万股,换手率0.01%,振幅5.08%。资金方面,该股资金流入19.544万港元,流出6.288万港元。东瑞制药股票所在的药品行业中,整体跌幅为0.26%。其相关个股中,艾美疫苗、中生联合、培力农本方涨幅较大,振幅较大的相关个股有前海健康、艾美疫苗、三爱健康集团,振幅分别为41.38%、16.62%、13.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011326497a486bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011326497a486bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2416756652","title":"东瑞制药(02348)股价上升5.085%,现价港币$1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2416756652","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416756652?lang=zh_cn&edition=full","pubTime":"2024-03-01 13:26","pubTimestamp":1709270760,"startTime":"0","endTime":"0","summary":"[上升股]东瑞制药(02348) 股价在下午01:26比前收市价上升5.085%,现股价为港币$1.24。至目前为止,今日最高价为$1.24,而最低价为$1.18。总成交量为22万股,总成交金额为港币$26.8万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403012015/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02348"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0588},{"period":"3month","weight":-0.0062},{"period":"6month","weight":0.0108},{"period":"1year","weight":0.0163},{"period":"ytd","weight":0.1268}],"compareEarnings":[{"period":"1week","weight":0.0268},{"period":"1month","weight":0.0087},{"period":"3month","weight":-0.0859},{"period":"6month","weight":0.0646},{"period":"1year","weight":-0.0212},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药(控股)有限公司是一家投资控股公司,主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.003449},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.004331},{"month":3,"riseRate":0.47619,"avgChangeRate":0.022591},{"month":4,"riseRate":0.714286,"avgChangeRate":0.040537},{"month":5,"riseRate":0.47619,"avgChangeRate":0.014967},{"month":6,"riseRate":0.571429,"avgChangeRate":0.007807},{"month":7,"riseRate":0.52381,"avgChangeRate":0.014054},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.015098},{"month":9,"riseRate":0.47619,"avgChangeRate":0.022916},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.004367},{"month":11,"riseRate":0.571429,"avgChangeRate":0.039387},{"month":12,"riseRate":0.571429,"avgChangeRate":0.014218}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}